Jenni Björnulfson
Amministratore Delegato presso LIDDS AB
Profilo
Jenni Björnulfson is currently the Chief Executive Officer, CFO & Head-IR at LIDDS AB.
She is also a Director at The C Story AB, a Manager-Business Area at GHP Specialty Care AB, and the Chief Financial Officer at Cinclus Pharma Holding AB.
Previously, she served as an Independent Director at Bio Vitos Pharma AB and as the Chief Financial Officer & Manager-IR at Promore Pharma AB from 2016 to 2020.
Ms. Björnulfson has an undergraduate degree from Karolinska Institutet and a graduate degree from Stockholm School of Economics.
Posizioni attive di Jenni Björnulfson
| Società | Posizione | Inizio |
|---|---|---|
| GHP SPECIALTY CARE AB (PUBL) | Corporate Officer/Principal | - |
| LIDDS AB | Amministratore Delegato | 01/12/2023 |
| The C Story AB | Direttore/Membro del Consiglio | - |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Direttore Finanziario/CFO | - |
Precedenti posizioni note di Jenni Björnulfson
| Società | Posizione | Fine |
|---|---|---|
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Direttore Finanziario/CFO | 25/08/2020 |
| BIO VITOS PHARMA AB | Direttore/Membro del Consiglio | - |
Formazione di Jenni Björnulfson
| Karolinska Institutet | Undergraduate Degree |
| Stockholm School of Economics | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| LIDDS AB | Health Technology |
| BIO VITOS PHARMA AB | Health Technology |
 | Health Technology |
| Aziende private | 3 |
|---|---|
GHP Specialty Care AB
 GHP Specialty Care AB Medical/Nursing ServicesHealth Services GHP Specialty Care AB engages in the provision of healthcare services. It operates business through the Nordic Region and Rest of the World segments. The Nordic Region segment conducts business within specialist care, such as spine surgery/spine care, orthopaedics, obesity surgery and diabetes care, gastroenterology, urology, gynaecology, general surgery, arrhythmia, maternal health care, plastic surgery, and specialist dentistry. The Rest of the World segment manages business in the field of diabetes care at one clinic in the United Arab Emirates. The company was founded by Per Båtelson and Johan Wachtmeister in 2006 and is headquartered in Göteborg, Sweden. | Health Services |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
| The C Story AB |
- Borsa valori
- Insiders
- Jenni Björnulfson
